VIDAPIN-50

Description

VIDAPIN-50 contains Vildagliptin 50 mg in tablet form. Vildagliptin belongs to the DPP-4 inhibitor class of oral antidiabetic medicines. It helps improve blood glucose control by enhancing glucose-dependent insulin release and reducing inappropriate glucagon activity. Therefore, healthcare professionals may prescribe VIDAPIN-50 for adults with type 2 diabetes mellitus alongside appropriate diet and exercise.

For related diabetic and cardiovascular formulations, explore the Cardries Biotic range from Medhexa Pharma for pharmaceutical products and business enquiries.

Therapeutic Segment

Anti-Diabetic Therapy | Type 2 Diabetes Management | DPP-4 Inhibitors | Blood Glucose Control | Glycemic Management

Uses of VIDAPIN-50

VIDAPIN-50 may support an individualized treatment plan for adults with type 2 diabetes mellitus.

Depending on the patient’s treatment needs, healthcare professionals may use vildagliptin:

• Alongside diet and exercise to improve glycaemic control
• As monotherapy when Metformin is inappropriate because of contraindications or intolerance
• With other diabetes medicines when existing treatment does not provide adequate glycaemic control
• As part of long-term blood glucose management under medical supervision

Vildagliptin does not replace insulin in patients who require insulin therapy. In addition, healthcare professionals do not use it to treat type 1 diabetes or diabetic ketoacidosis.

Key Benefits of VIDAPIN-50

• Supports Blood Glucose Control: Vildagliptin helps improve glycaemic control in adults with type 2 diabetes.
• DPP-4 Inhibitor Action: It inhibits the DPP-4 enzyme and increases the activity of incretin hormones.
• Supports Glucose-Dependent Insulin Release: As a result, the pancreas can release insulin more effectively when blood glucose rises.
• Helps Regulate Glucagon: Vildagliptin reduces inappropriate glucagon activity during elevated blood glucose levels.
• Supports Combination Therapy: Doctors may combine vildagliptin with other antidiabetic medicines when additional glycaemic control is needed.
• Convenient Oral Formulation: VIDAPIN-50 comes as tablets in 10 × 15 ALU-ALU packaging.

How VIDAPIN-50 Works

Vildagliptin acts as a selective DPP-4 inhibitor. Normally, the DPP-4 enzyme breaks down incretin hormones such as GLP-1 and GIP.

However, vildagliptin inhibits DPP-4 activity. Consequently, incretin hormones remain active for longer. This action helps pancreatic beta cells respond to elevated glucose by increasing glucose-dependent insulin secretion.

At the same time, vildagliptin helps alpha cells regulate glucagon secretion according to blood glucose levels. Together, these effects help improve glycaemic control in adults with type 2 diabetes.

Common Side Effects of VIDAPIN-50

Some patients may experience side effects during treatment. These can include:

• Headache
• Dizziness
• Tremor
• Nausea
• Gastrointestinal discomfort
• Constipation
• Fatigue
• Joint pain
• Muscle pain
• Peripheral swelling

In addition, hypoglycaemia can occur, particularly when vildagliptin is used with insulin or a sulfonylurea. Patients should follow their healthcare professional’s advice about blood glucose monitoring and other diabetes medicines.

Important Safety Information

Use VIDAPIN-50 only under the direction of a qualified healthcare professional.

• Follow the prescribed dose and continue the recommended diabetes-management plan.
• Check blood glucose as advised by your healthcare professional.
• Tell your doctor if you have kidney disease, because renal impairment can affect vildagliptin exposure and may require a lower dose.
• Current prescribing information recommends 50 mg once daily for patients with moderate or severe renal impairment or end-stage renal disease.
• Tell your doctor if you have liver disease or abnormal liver enzyme results.
• Healthcare professionals generally check liver function before starting vildagliptin and monitor it during treatment because rare cases of hepatic dysfunction have occurred.
• Contact your doctor if you notice yellowing of the skin or eyes, dark urine or other symptoms that may indicate liver problems.
• Tell your healthcare professional if you have previously experienced pancreatitis or develop persistent, severe abdominal pain.
• Watch for symptoms of low blood sugar, especially when you use VIDAPIN-50 with insulin or a sulfonylurea.
• Inform your doctor about all prescription medicines, vitamins, supplements and herbal products you take.
• VIDAPIN-50 does not treat type 1 diabetes or diabetic ketoacidosis.
• Do not stop or change the dose without medical advice.

For detailed prescribing information and safety precautions, refer to the Vildagliptin 50 mg Summary of Product Characteristics.

Dosage & Administration

Take VIDAPIN-50 exactly as prescribed by your healthcare professional.

The appropriate regimen depends on the patient’s diabetes treatment, kidney function and response to therapy. For example, prescribing information uses different vildagliptin regimens depending on whether the medicine is used alone, with Metformin, with a sulfonylurea or with other antidiabetic medicines. Therefore, patients should follow the specific prescription rather than selecting a dose themselves.

Patients can generally take vildagliptin with or without food. Swallow the tablet with water unless your healthcare professional gives different instructions.

If you miss a dose, take it when you remember unless it is nearly time for the next dose. However, do not take two doses together on the same day.

Storage

• Store VIDAPIN-50 in a cool, dry place.
• Protect the tablets from excessive moisture.
• Keep the tablets in their original ALU-ALU packaging until use.
• Keep the product away from direct sunlight and excessive heat.
• Keep out of the sight and reach of children.
• Do not use the medicine after the expiry date printed on the pack.